Theriva Biologics anuncia el desdoblamiento inverso de sus acciones
ROCKVILLE, Md., Aug. 17, 2024 (GLOBE NEWSWIRE) — Theriva Biologics, Inc. (NYSE American: TOVX), una empresa diversificada de fase clínica […]
Oragenics, Inc. Provides Update on its Drug Intended to Treat Concussion and Non-Compliance with NYSE American Continued Listing Standards
SARASOTA, Fla., Aug. 16, 2024 (GLOBE NEWSWIRE) — Oragenics, Inc. (NYSE American: OGEN) (“the Company”), a company focused on developing […]
Theriva Biologics Announces Reverse Stock Split
ROCKVILLE, Md., Aug. 16, 2024 (GLOBE NEWSWIRE) — Theriva Biologics, Inc. (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics […]
Weekly Report (August 9-15, 2024) Third Tranche of Stellantis 2024 Share Buyback Program
AMSTERDAM, August 16, 2024 – Stellantis N.V. (“Stellantis” or the “Company”) announced today that pursuant to its Third Tranche of […]
UPDATE ON UNITS – BiomX Inc. Announces 1-for-10 Reverse Stock Split
In a release issued under the same headline yesterday by BiomX (NYSE American: PHGE), the third and fourth paragraphs have […]
Apollo Funds, together with Rettig, complete the acquisition of a 94.53% stake in Purmo Group Plc
NEW YORK, Aug. 16, 2024 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) today announced that Apollo-managed funds associated with its Clean […]
Opus One Expands Chart Industries’ CO2 Capture Solution for Third Year
ATLANTA, Aug. 16, 2024 (GLOBE NEWSWIRE) — A pioneer in ultra-premium winemaking in Napa Valley, Opus One Winery is among […]
Lithium Argentina Closes Pastos Grandes Transaction with Ganfeng Lithium
VANCOUVER, British Columbia, Aug. 16, 2024 (GLOBE NEWSWIRE) — Lithium Americas (Argentina) Corp. (TSX/NYSE: LAAC) (“Lithium Argentina” or the “Company”) is […]
Sysco Announces New Director to Board
HOUSTON, Aug. 16, 2024 (GLOBE NEWSWIRE) — Sysco Corporation (NYSE:SYY), the world’s largest food distributor, announced today that Roberto Marques […]
AIM ImmunoTech Reports Second Quarter 2024 Financial Results and Provides Corporate Update
– Continued execution across Ampligen® clinical development programs and growing body of positive data in multiple high-value indications – Company […]
